Table 3.
Test for the difference between demographic and biochemical characteristics of patients with IVF negative and positive pregnancy outcome.
| Negative IVF pregnancy outcome (n = 10) |
Positive IVF pregnancy outcome (n = 5) |
p Value | |||
|---|---|---|---|---|---|
| Mean ± SD | Median (range) | Mean ± SD | Median (range) | ||
| Age (years) | 28.6 ± 4.0 | 28.0 (23.0–35.0) | 30.0 ± 4.4 | 28.0 (27.0–35.0) | 0.538 |
| FSH (mIU/ml) | 5.5 ± 1.3 | 6.0 (3.8–7.0) | 5.8 ± 2.8 | 5.2 (3.4–9.4) | 0.705 |
| LH (mIU/ml) | 5.7 ± 4.5 | 4.9 (1.0–15.0) | 3.8 ± 1.5 | 3.5 (2.0–6.0) | 0.450 |
| E2 (pg/ml) | 52.1 ± 8.9 | 49 (44.0–67.0) | 46.7 ± 15.0 | 48.0 (31.0–61.0) | 0.569 |
| End. thickness (mm) | 12.4 ± 1.6 | 12.0 (10.0–15.0) | 11.0 ± 1.4 | 11.0 (9.0–13.0) | 0.117 |
| IL-11 | 12.5 ± 0.9 | 12.7 (11.4–13.9) | 12.7 ± 0.6 | 12.9 (11.8–13.3) | 0.667 |
| IL-11Rα | 9.7 ± 0.8 | 9.3 (8.7–11.2) | 9.9 ± 1.0 | 9.7 (8.6–11.1) | 0.539 |
| LIF | 12.3 ± 1.0 | 12.5 (10.6–13.3) | 11.5 ± 0.8 | 11.6 (10.5–12.4) | 0.140 |
FSH: Follicular stimulating hormone (mIU/ml), LH: Luteinizing hormone (mIU/ml), E2: Estradiol (pg/ml) and End. thickness: Endometrial thickness (mm). p Value: indicates significant value when < 0.05.